FdaApplication
NDA 021572
Identifiers
- fda_app_no: NDA021572
Properties
| Property | Value |
|---|---|
| applicant_name | CUBIST PHARMACEUTICALS LLC |
| application_type | NDA |
| approval_date | 2003-09-12 |
Products (3)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| CUBICIN | DAPTOMYCIN | 250MG/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | POWDER;INTRAVENOUS |
| CUBICIN | DAPTOMYCIN | 500MG/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | POWDER;INTRAVENOUS |
| CUBICIN RF | DAPTOMYCIN | 500MG/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | POWDER;INTRAVENOUS |
3 products